Grifols S.A. | Mutual Funds
Mutual Funds that own Grifols S.A.
Oppenheimer International Growth Fund
12,605,881
2.96%
-541,570
1.41%
05/31/2018
Jupiter European Fund
10,375,000
2.44%
120,000
3.9%
02/28/2018
American Funds EuroPacific Growth Fund
6,401,000
1.5%
0
0.13%
06/30/2018
Government Pension Fund - Global (The)
5,738,004
1.35%
612,181
0.02%
12/31/2017
Vanguard Total International Stock Index Fund
5,253,026
1.23%
115,901
0.04%
07/31/2018
DWS European Opportunities
4,705,059
1.1%
3,977,712
3.34%
07/31/2018
Jupiter Global Fund - European Growth Fund
4,282,000
1%
62,000
3.91%
02/28/2018
Harding Loevner International Equity Portfolio
2,272,946
0.53%
117,653
0.47%
06/30/2018
Universal Invest Global Flexible
2,257,200
0.53%
0
0.6%
06/30/2018
Fidelity Funds SICAV - Iberia Fund
2,248,965
0.53%
-124,930
8.72%
05/31/2018
| Address |
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
|
|
Employees
|
- |
| Website |
http://www.grifols.com |
| Updated |
07/08/2019 |
| Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. |
